At Oncogen Pharma, we are committed to pushing the boundaries of scientific innovation and making breakthroughs in the field of oncology. Our research and development (R&D) efforts are focused on developing novel and effective treatments for cancer patients, addressing unmet medical needs, and improving patient outcomes.
BECOMING TECHNOLOGY LEADER
Research and Development Facilities
Oncogen Pharma takes pride in its state-of-the-art research and development facilities. Our global R&D center in Malaysia is an exclusive, multiproduct, high-containment facility, dedicated to developing innovative oncology drugs. Equipped with cutting-edge technologies and advanced laboratory infrastructure, our R&D center fosters a collaborative and dynamic environment for scientists to explore new avenues in cancer research. We constantly invest in upgrading our facilities to ensure that our researchers have access to the latest tools and resources.
BECOMING TECHNOLOGY LEADER
Research and Development Facilities
Oncogen Pharma takes pride in its state-of-the-art research and development facilities. Our global R&D center in Malaysia is an exclusive, multiproduct, high-containment facility, dedicated to developing innovative oncology drugs. Equipped with cutting-edge technologies and advanced laboratory infrastructure, our R&D center fosters a collaborative and dynamic environment for scientists to explore new avenues in cancer research. We constantly invest in upgrading our facilities to ensure that our researchers have access to the latest tools and resources.
Research & Development Commitment
At Oncogen Pharma, we are committed to achieving excellence in quality standards through our R&D efforts. Our commitments are centered around three key pillars:
Through our robust R&D capabilities and unwavering commitments, we strive to make significant contributions to the field of oncology. Our research efforts are driven by a passion for improving patient outcomes, providing innovative treatments, and ultimately helping people regain their health and quality of life.
Systematic Drug Development
We follow a systematic drug development approach in accordance with global regulatory requirements. Our dedicated team of scientists and researchers works tirelessly to develop new medications, focusing on safety, efficacy, and compliance. All our products are first developed and tested in our Global Research & Development (R&D) center in Malaysia. Then the technology is transferred to Oncogen Pharma Pakistan. By employing sophisticated technologies and advanced methodologies, we aim to bring innovative and effective treatments to patients in need.
Higher Quality Levels
We maintain a comprehensive quality management system to ensure that our products meet the highest quality standards. Through the use of sophisticated technology and ongoing quality improvements, we strive for higher quality levels in our products, processes, and systems. By prioritizing training and awareness among our staff, we foster a culture of quality, safety, and integrity across all facets of our operations.
Higher Quality Levels
We maintain a comprehensive quality management system to ensure that our products meet the highest quality standards. Through the use of sophisticated technology and ongoing quality improvements, we strive for higher quality levels in our products, processes, and systems. By prioritizing training and awareness among our staff, we foster a culture of quality, safety, and integrity across all facets of our operations.
Continuous Innovation
Innovation is at the core of our R&D efforts. We emphasize the development of new products, processes, and markets to address unmet patient needs. By engaging our scientists early in the strategic development of new products, we can optimize processes, minimize regulatory hurdles, and ensure the most efficient pathways to commercial manufacturing. Our R&D team is dedicated to pushing the boundaries of scientific knowledge, enabling us to stay at the forefront of oncology drug development.
